Merck’s COVID Drug Molnupiravir Expected to Hit Chinese Market on Friday

According to the official website of the Tianjin Medical Purchasing Center, the price of Molnupiravir, a COVID-19 drug developed by US pharmaceutical company Merck, was 1,500 yuan ($222) per bottle of 40 capsules…
Read More